Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines

Sidney S Braman, Sidney S Braman

Abstract

Background: The purpose of this review is to present the evidence for the diagnosis and treatment of cough due to acute bronchitis and make recommendations that will be useful for clinical practice. Acute bronchitis is one of the most common diagnoses made by primary care clinicians and emergency department physicians. It is an acute respiratory infection with a normal chest radiograph that is manifested by cough with or without phlegm production that lasts for up to 3 weeks. Respiratory viruses appear to be the most common cause of acute bronchitis; however, the organism responsible is rarely identified in clinical practice because viral cultures and serologic assays are not routinely performed. Fewer than 10% of patients will have a bacterial infection diagnosed as the cause of bronchitis. The diagnosis of acute bronchitis should be made only when there is no clinical or radiographic evidence of pneumonia, and the common cold, acute asthma, or an exacerbation of COPD have been ruled out as the cause of cough. Acute bronchitis is a self-limited respiratory disorder, and when the cough persists for >3 weeks, other diagnoses must be considered.

Methods: Recommendations for this review were obtained from data using a National Library of Medicine (PubMed) search dating back to 1950, which was performed in August 2004. The search was limited to literature published in the English language and human studies, using search terms such as "cough," "acute bronchitis," and "acute viral respiratory infection."

Results: Unfortunately, most previous controlled trials guiding the treatment of acute bronchitis have not vigorously differentiated acute bronchitis and the common cold, and also have not distinguished between an acute exacerbation of chronic bronchitis and acute asthma as a cause of acute cough. For patients with the putative diagnosis of acute bronchitis, routine treatment with antibiotics is not justified and should not be offered. Antitussive agents are occasionally useful and can be offered as therapy for short-term symptomatic relief of coughing, but there is no role for inhaled bronchodilator or expectorant therapy. Children and adult patients with confirmed and probable whooping cough should receive a macrolide antibiotic and should be isolated for 5 days from the start of treatment; early treatment within the first few weeks will diminish the coughing paroxysms and prevent spread of the disease; the patient is unlikely to respond to treatment beyond this period.

Conclusion: Acute bronchitis is an acute respiratory infection that is manifested by cough and, at times, sputum production that lasts for no more than 3 weeks. This syndrome should be distinguished from the common cold, an acute exacerbation of chronic bronchitis, and acute asthma as the cause of acute cough. The widespread use of antibiotics for the treatment of acute bronchitis is not justified, and vigorous efforts to curtail their use should be encouraged.

References

    1. Gonzales R, Sande M. Uncomplicated acute bronchitis. Ann Intern Med. 2000;133:981–991.
    1. Terho H, Asko J. The common cold. Lancet. 2003;361:51–59.
    1. Curley F, Irwin R, Pratter M. Cough and the common cold. Am Rev Respir Dis. 1988;138:305–311.
    1. Verheij T, Hermans J, Kaptein A. Acute bronchitis: general practitioners' views regarding diagnosis and treatment. Fam Pract. 1990;7:175–180.
    1. Oeffinger K, Snell L, Foster B. Treatment of acute bronchitis in adults: a national survey of family physicians. J Fam Pract. 1998;46:469–475.
    1. Thiadens H, Postma D, DeBock G. Asthma in adult patients presenting with symptoms of acute bronchitis in general practice. Scand J Prim Health Care. 2000;18:188–192.
    1. Jonsson J, Gislason T, Gislason D. Acute bronchitis and clinical outcome three years later: prospective cohort study. BMJ. 1998;317:1433–1434.
    1. Hallett J, Jacobs R. Recurrent acute bronchitis: the association with undiagnosed asthma. Ann Allergy. 1985;55:568–570.
    1. Schappert S. Ambulatory care visits to physicians offices, hospital outpatient departments, and emergency departments, United States, 1997. 1997 National Center for Health Statistics. Hyattsville, MD:
    1. Gonzales R, Wilson A, Crane L. What's in a name? Public knowledge, attitude, and experiences with antibiotic use for acute bronchitis. Am J Med. 2000;108:83–85.
    1. Adams P, Hendershot G, Marano M. Current estimates from the National Health Interview Survey, United States, 1996. 1999 US Department of Health and Human Services, Public Health Service, Office of Health Research, Statistics, and Technology, National Center for Health Statistics. Hyattsville, MD:
    1. Armstrong G, Pinner R. Outpatient visits for infectious diseases in the United States: 1980 through 1996. Arch Intern Med. 1999;159:2531–2536.
    1. Jonsson J, Sigurdsson J, Kristonsson K. Acute bronchitis in adults. How close do we come to its aetiology in general practice? Scand J Prim Health Care. 1997;15:156–160.
    1. Boldy D, Skidmore S, Ayeres J. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med. 1990;84:377–385.
    1. Monto A, Gravenstein S, Elliot M. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–3247.
    1. Hall C, Geiman J, Biggar R. Respiratory syncytial infections within families. N Engl J Med. 1976;294:414–419.
    1. Agius G, Dindinaud G, Biggar R. An epidemic of respiratory syncytial virus in elderly people: clinical and serologic findings. J Med Virol. 1990;30:117–127.
    1. Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Res. 1999;44:79–102.
    1. Zambon M, Stockton J, Clewley J. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358:1410–1416.
    1. Booth C, Matukas L, Thomlinson G. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809.
    1. Liu CL, Lu YT, Peng MJ. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest. 2004;126:509–517.
    1. Wadowsky R, Castilla E, Laus S. Evaluation onChlamydia pneumoniaeandMycoplasma pneumoniaeas etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol. 2002;40:637–640.
    1. Vincent J, Cherry J, Nauscheutz W. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serologic search for causation. Clin Infect Dis. 2000;30:534–539.
    1. Davis S, Suter R, Strebel P. Concurrent outbreaks of pertussis andMycoplasma pneumoniaeinfection: clinical and epidemiologic characteristics of illness manifested by cough. Clin Infect Dis. 1995;20:621–628.
    1. Jackson L, Cherry J, Wang S. Frequency of serologic evidence of Bortetella infections and mixed respiratory infections with other respiratory pathogens in university students with cough illness. Clin Infect Dis. 2000;31:3–6.
    1. Henry D, Ruoff G, Rhudy J. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. Antimicrob Agents Chemother. 1995;39:2528–2534.
    1. McCrory D, Brown C, Gelfand S. Management of acute exacerbation of COPD: a summary and appraisal of published evidence. Chest. 2001;119:1190–1209.
    1. Hirschmann J. Antibiotics for common respiratory tract infections in adults. Arch Intern Med. 2002;162:256–264.
    1. Polito A, Proud D. Epithelia cells as regulators of airway inflammation. J Allergy Clin Immunol. 1998;102:714–718.
    1. Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Respir J. 1994;7:1239–1245.
    1. Williamson H. Pulmonary function tests in acute bronchitis: evidence for reversible airflow obstruction. J Fam Pract. 1987;25:251–256.
    1. Hall W, Hall C, Speers D. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med. 1978;88:203–205.
    1. Hall W, Hall C. Clinical significance of pulmonary function tests: alterations in pulmonary function following viral respiratory infection. Chest. 1979;76:458–465.
    1. Little J, Hall W, Douglas RJ. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis. 1978;118:295–303.
    1. Hallett J, Jacobs R. Recurrent acute bronchitis: the association with undiagnosed bronchial asthma. Ann Allergy. 1985;55:568–570.
    1. Hahn D. Chlamydia pneumoniaeand the “Dutch Hypothesis.”. Chest. 2002;122:1510–1512.
    1. Hahn D, Dodge R, Golubjatnikov R. Association ofChlamydia pneumoniae(strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 1991;266:225–230.
    1. Metlay J, Schulz R, Li Y. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157:1453–1459.
    1. Gennis P, Gallagher J, Falvo C. Clinical criteria for the detection of pneumonia in adults: guidelines for ordering chest roentgenograms in the emergency department. J Emerg Med. 1989;7:263–268.
    1. Diehr P, Wood R, Bushyhead J. Prediction of pneumonia in outpatients with acute cough: a statistical approach. J Chronic Dis. 1984;37:215–225.
    1. Heckerling P, Tape T, Wigton R. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med. 1990;113:664–670.
    1. Singal B, Hedges J, Radack K. Decision rules and clinical prediction of pneumonia: evaluation of low-yield criteria. Ann Emerg Med. 1989;18:13–20.
    1. Metlay J, Kapoor W, Fine M. Does this patient have community acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA. 1997;278:1440–1445.
    1. Linder J, Sim I. Antibiotic treatment of acute bronchitis in smokers. J Gen Intern Med. 2002;17:230–234.
    1. Steinman M, Sauaia A, Masseli J. Office evaluation and treatment of elderly patients with acute bronchitis. J Am Geriatr Soc. 2004;52:875–879.
    1. Steinman M, Landefeld C, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289:719–725.
    1. Gonzales R, Brrtlett J, Besser R. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001;134:521–529.
    1. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med. 2001;134:518–520.
    1. Williamson HA., Jr A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract. 1984;19:481–486.
    1. Stott NC, West RR. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. BMJ. 1976;2:556–559.
    1. Verheij TJ, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract. 1994;44:400–404.
    1. Scherl ER, Riegler SL, Cooper JK. Doxycycline in acute bronchitis: a randomized double-blind trial. J Ky Med Assoc. 1987;85:539–541.
    1. Peralta J, Poderoso JJ, Corazza C. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis. Arzneimittelforschung. 1987;37:969–971.
    1. Gottfarb P, Brauner A. Children with persistent cough: outcome with treatment and role ofMoraxella catarrhalis? Scand J Infect Dis. 1994;26:545–551.
    1. Franks P, Gleiner JA. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract. 1984;19:185–190.
    1. Dowell J, Pitkethly M, Bain J. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract. 2001;51:200–205.
    1. King DE, Williams WC, Bishop L. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract. 1996;42:601–605.
    1. Dunlay J, Reinhardt R, Roi LD. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract. 1987;25:137–141.
    1. Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract. 1986;23:119–122.
    1. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract. 1994;39:437–440.
    1. Smucny J, Flynn C, Becker L. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev (database online) 2004 Issue 1.
    1. Lee P, Jawad M, Eccles R. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory infection. J Pharm Pharmacol. 2000;52:1139–1142.
    1. Pavesi L, Subburaj S, Porter-Shaw K. Application and validation of a computerized cough acquisition system for objective monitoring of acute cough. Chest. 2001;120:1121–1128.
    1. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with the common cold. J Pharm Pharmacol. 1997;49:1045–1049.
    1. Tukiainen H, Karttunen P, Silvasti M. The treatment of acute transient cough: a placebo-controlled comparison of dextromethorphan-β2 sympathomimetic combination. Eur J Respir Dis. 1986;69:95–99.
    1. Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (database online) 2004;(4)

Source: PubMed

Подписаться